University of Minnesota: Respiratory Distress Syndrome trials

The registry lists 11 Respiratory Distress Syndrome studies with University of Minnesota as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 2 4Phase 3 2No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Pre-exposure Prophylaxis for SARS-Coronavirus-2CompletedNCT04328467Phase 3Results posted
• Losartan for Patients With COVID-19 Requiring HospitalizationCompletedNCT04312009Phase 2Results posted
• Losartan for Patients With COVID-19 Not Requiring HospitalizationCompletedNCT04311177Phase 2Results posted
• Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2CompletedNCT04308668Phase 3Results posted
• Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress SyndromeCompletedNCT02582957Not applicableResults posted
• Diaphragm Ultrasound Vs Transpulmonary Pressure To Set PEEP in ARDSCompletedNCT02463773Not applicableResults posted
• Laryngeal Mask Airway (LMA) for Surfactant Administration in NeonatesCompletedNCT01116921Not applicableResults posted
• Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress SyndromeWithdrawnNCT04725110Phase 2
• A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP CircuitsCompletedNCT04311320Not applicable
• Treatment of ARDS With Instilled T3Active, not recruitingNCT04115514Phase 2
• ARDS - Clinical Epidemiology and the Role of the Inflammatory Response - SCOR in Acute Lung InjuryCompletedNCT00005318